Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

515 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multistep approach to improving biopsy site identification in dermatology: physician, staff, and patient roles based on a Delphi consensus.
Alam M, Lee A, Ibrahimi OA, Kim N, Bordeaux J, Chen K, Dinehart S, Goldberg DJ, Hanke CW, Hruza GJ, Nehal KS, Olbricht SM, Orringer J, Rohrer TE, Scheinfeld NS, Schmults CD, Strasswimmer JM, Taylor JS, Yoo S, Nodzenski M, Poon E, Cartee T; Cutaneous Surgery Consensus Group. Alam M, et al. Among authors: poon e. JAMA Dermatol. 2014 May;150(5):550-8. doi: 10.1001/jamadermatol.2013.9804. JAMA Dermatol. 2014. PMID: 24599088 Review.
The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial.
Ibrahim O, Kakar R, Bolotin D, Nodzenski M, Disphanurat W, Pace N, Becker L, West DP, Poon E, Veledar E, Alam M. Ibrahim O, et al. Among authors: poon e. J Am Acad Dermatol. 2013 Jul;69(1):88-95. doi: 10.1016/j.jaad.2013.02.013. Epub 2013 Apr 13. J Am Acad Dermatol. 2013. PMID: 23591103 Clinical Trial.
Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: A double-blind randomized controlled trial.
Alam M, Voravutinon N, Warycha M, Whiting D, Nodzenski M, Yoo S, West DP, Veledar E, Poon E. Alam M, et al. Among authors: poon e. J Am Acad Dermatol. 2013 Sep;69(3):438-43. doi: 10.1016/j.jaad.2013.04.015. Epub 2013 May 17. J Am Acad Dermatol. 2013. PMID: 23688651 Clinical Trial.
Floaters in Mohs micrographic surgery.
Alam M, Shah AD, Ali S, Rauf M, Nodzenski M, Ibrahim O; Mohs Consensus Conference. Alam M, et al. Dermatol Surg. 2013 Sep;39(9):1317-22. doi: 10.1111/dsu.12258. Epub 2013 Jun 27. Dermatol Surg. 2013. PMID: 23809022
Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers.
Alam M, Ibrahim O, Nodzenski M, Strasswimmer JM, Jiang SI, Cohen JL, Albano BJ, Batra P, Behshad R, Benedetto AV, Chan CS, Chilukuri S, Crocker C, Crystal HW, Dhir A, Faulconer VA, Goldberg LH, Goodman C, Greenbaum SS, Hale EK, Hanke CW, Hruza GJ, Jacobson L, Jones J, Kimyai-Asadi A, Kouba D, Lahti J, Macias K, Miller SJ, Monk E, Nguyen TH, Oganesyan G, Pennie M, Pontius K, Posten W, Reichel JL, Rohrer TE, Rooney JA, Tran HT, Poon E, Bolotin D, Dubina M, Pace N, Kim N, Disphanurat W, Kathawalla U, Kakar R, West DP, Veledar E, Yoo S. Alam M, et al. Among authors: poon e. JAMA Dermatol. 2013 Dec;149(12):1378-85. doi: 10.1001/jamadermatol.2013.6255. JAMA Dermatol. 2013. PMID: 24080866
Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial.
Dubina M, Tung R, Bolotin D, Mahoney AM, Tayebi B, Sato M, Mulinari-Brenner F, Jones T, West DP, Poon E, Nodzenski M, Alam M. Dubina M, et al. Among authors: poon e. J Cosmet Dermatol. 2013 Dec;12(4):261-6. doi: 10.1111/jocd.12059. J Cosmet Dermatol. 2013. PMID: 24305424 Clinical Trial.
Multicenter prospective cohort study of the incidence of adverse events associated with cosmetic dermatologic procedures: lasers, energy devices, and injectable neurotoxins and fillers.
Alam M, Kakar R, Nodzenski M, Ibrahim O, Disphanurat W, Bolotin D, Borovicka JH, Pace N, Alster TS, Arndt KA, Beer KR, Berlin JM, Bernstein LJ, Brightman LA, Butterwick K, Cox SE, Chotzen V, Fabi SG, Fitzpatrick RE, Geronemus RG, Goldman MP, Groff WF, Kaminer MS, Kilmer S, Rohrer TE, Tanzi EL, Silva SK, Yoo SS, Weinkle SH, Strasswimmer J, Poon E, Dover JS. Alam M, et al. Among authors: poon e. JAMA Dermatol. 2015 Mar;151(3):271-7. doi: 10.1001/jamadermatol.2014.2494. JAMA Dermatol. 2015. PMID: 25372511
515 results